StandUPTV Habits: Feasibility Trial for Maintaining Reductions in Sedentary Screen Time
Launched by ARIZONA STATE UNIVERSITY · Nov 20, 2024
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
The StandUPTV Habits trial is designed to help adults reduce the amount of time they spend in front of screens while sitting down, which is known as Sedentary Screen Time (SST). The study aims to test a mobile app called StandUPTV, which sends alerts to encourage participants to get up and move after they've been sitting and watching screens for about 30 minutes in the evening. This program hopes to create healthier habits that can lead to improvements in physical activity, sleep quality, and overall health.
To join this study, participants should not be very active—meaning they don’t meet the recommended 150 minutes of moderate physical activity each week—and should spend more than 3 hours a day on sedentary screen activities. Eligible participants must also have an Android smartphone, be able to read and understand English, and be willing to wear specific devices to track their activity. It's important to note that individuals with certain health conditions, such as diabetes or serious illnesses, cannot participate. If you decide to join, you’ll receive support through the app and your progress will be monitored, helping you to develop healthier habits over the four-month period of the trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Insufficiently active as defined by not meeting current US National Guidelines for Physical Activity of 150 minutes of MVPA/week (Measured by the Stanford
- • Leisure-Time Activity Categorical Item)
- • \> 3 hours of SST per day
- • Use Android (8.0+) smartphone (8.0+ represents 95% of Android device coverage per https://apilevels.com/)
- • Have regular broadband internet in their home or an unlimited data plan
- • Able to read/understand English (\>5th grade literacy)
- • Willing to download StandUPTV Habits
- • Willing to wear activPAL and CGM device during study assessment periods
- • Willing to have data shared in de-identified form in Dexcom Clarity platform
- • Willing to be randomized to either study condition
- • Not traveling overnight or longer in the next 4 months
- Exclusion Criteria:
- • Planned relocation
- • Current smoker
- • Have a major illness (e.g., heart disease, cancer, renal disease) for which MVPA is contraindicated
- • Diagnosed with diabetes or gestational diabetes in the past
- • Currently using a CGM
- • Pregnant
- • Occupation that requires substantial use of personal device for media-related activities (e.g., social media)
- • Drug abuse
- • Serious psychological disorder
- • Not willing to use Fitbit or smart plugs for calculation of sedentary screen time for functionality of StandUPTV app
About Arizona State University
Arizona State University (ASU) is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, ASU leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the scientific community. With a commitment to ethical research practices and collaboration with healthcare professionals, ASU strives to translate research findings into practical applications that benefit society. The university's focus on community engagement and real-world impact underscores its role as a pivotal player in the advancement of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tempe, Arizona, United States
San Luis Obispo, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported